Surgery versus radiofrequency ablation for small hepatocellular carcinoma: Start of a randomized controlled trial (SURF trial)

Hepatology Research

Volumn 40, Issue 8, 2010, Pages 851-852

  Kiyoshi, Hasegawa ^a   Norihiro, Kokudo ^a   Shuichiro, Shiina ^b   Ryosuke, Tateishi ^b   Masatoshi, Makuuchi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 77955255388     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00696.x     Document Type: Letter

References (5)

1. Huang GT, Lee PH, Tsang YM. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005, 242:36-42.
2. Chen MS, Li JQ, Zheng Y. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for hepatocellular carcinoma. Ann Surg 2006, 243:321-8.
3. Arii S, Yamaoka Y, Futagawa S. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000, 32:1224-9.
4. Hasegawa K, Makuuchi M, Takayama T. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008, 49:589-94. for the Liver Cancer Study Group of Japan
5. Llovet JM, Di Bisceglie AM, Bruix J. Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008, 100:698-711.